MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$33,301K
Free Cash flow
-$18,799K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Proceeds from exercises of stock...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other curre...
Lease liabilities, net
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-24,657
-18,581
-17,433
-55,348
Depreciation
88
88
93
90
Amortization of intangible assets
166
167
166
166
Stock-based compensation
4,973
1,912
4,970
5,617
Non-cash lease expense
317
308
306
847
Write-off of deferred issuance costs
0
281
-
-
Loss on disposal of fixed assets
-
-
0
-
Other
-12
-62
-
-
Accounts receivable
-43
-55
259
15
Inventory
30
70
79
57
Prepaid expenses and other current assets
433
129
374
538
Other receivables
-
-
-
14
Other non-current assets
-4
-3
-14
28
Accounts payable
139
-148
-186
1,318
Accrued liabilities
1,052
1,832
-1,627
-1,823
Lease liabilities, net
-383
-375
-360
-1,008
Net cash used in operating activities
-18,709
-14,595
-14,755
-13,039
Purchases of property and equipment
90
33
105
62
Purchases of intangible assets
0
-
0
0
Net cash used in investing activities
-90
-33
-105
-62
Proceeds from issuance of common stock under at-the-market offering program, net of issuance costs
46,392
-
-
-
Proceeds from exercises of stock options
5,612
1,674
387
1,708
Proceeds from issuance of common stock and warrants in relation to rights offering, net of issuance costs
-
-
0
0
Proceeds from exercises of warrants, net of issuance costs
39
130
1
17
Payment of deferred issuance costs in relation to registration statements
-
57
0
0
Proceeds from issuance of common stock under employee stock purchase plan
0
465
-7
241
Net cash provided by financing activities
52,100
2,212
381
1,966
Net increase (decrease) in cash and cash equivalents
33,301
-12,416
-14,479
-11,135
Cash and cash equivalents at beginning of period
95,214
95,214
-
118,038
Cash and cash equivalents at end of period
101,620
68,319
-
95,214
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock under...
$46,392K
Proceeds from exercises
of stock options
$5,612K
(1331.63%↑ Y/Y)
Proceeds from exercises
of warrants, net of...
$39K
(-99.72%↓ Y/Y)
Net cash provided by
financing activities
$52,100K
(251.86%↑ Y/Y)
Net increase
(decrease) in cash and cash...
$33,301K
(384.89%↑ Y/Y)
Canceled cashflow
$18,799K
Stock-based compensation
$4,973K
(-54.25%↓ Y/Y)
Accrued liabilities
$1,052K
Non-cash lease expense
$317K
Amortization of intangible
assets
$166K
(-50.15%↓ Y/Y)
Accounts payable
$139K
Depreciation
$88K
(-60.54%↓ Y/Y)
Accounts receivable
-$43K
Other
-$12K
Other non-current
assets
-$4K
Net cash used in
operating activities
-$18,709K
(28.94%↑ Y/Y)
Net cash used in
investing activities
-$90K
(46.43%↑ Y/Y)
Canceled cashflow
$6,794K
Net loss
-$24,657K
Purchases of property and
equipment
$90K
(-39.19%↓ Y/Y)
Prepaid expenses and
other current assets
$433K
Lease liabilities,
net
-$383K
Inventory
$30K
Buy us a coffee
PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. (PLSE)